Stephen Hahn, MD, recent FDA Commissioner, joins Blackfynn Board of Directors

Retrieved on: 2021-02-23 12:00:00

Tags for this article:

Life Sciences

Health sciences

Health

Drug discovery

Pharmaceutical industry

Neurodegenerative disorders

Parkinson's disease

Psychiatric diagnosis

The Michael J. Fox Foundation

Drug development

Food and Drug Administration

Cynapsus Therapeutics

Blackfynn

Click the tags to see associated articles and topics

Stephen Hahn, MD, recent FDA Commissioner, joins Blackfynn Board of Directors. View article details on hiswai:

Excerpt

Fox Foundation for Parkinson's Research to support the data acquisition and analysis needs of its landmark Parkinson's Progression Markers Initiative ( ...

Article found on: www.prnewswire.com

View Original Article